Glucocorticoids are used in ALL treatment for their cytotoxicity induction properties that lead to cellular apoptosis (Gaynon and Carrel 1999) and resistance to their effects is the main cause of treatment failure in MLL-rearranged infant ALL (Pieters et al. 1998). This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.